Previous work with keratinocytes and keratinocyte-derived SCC cells has shown that CEACAM6 is selectively expressed in differentiated keratinocytes[2] and is highly expressed in a tumourigenic clonal variant of the Detroit 562 HNSCC cell line[10]. This evidence concerns the gene CEACAM6 and head and neck squamous cell carcinoma.